Sandbox c12

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 7: Line 7:
It was the first centrally-acting cholinesterase inhibitor approved for the treatment of Alzheimer's disease.
It was the first centrally-acting cholinesterase inhibitor approved for the treatment of Alzheimer's disease.
-
<scene name='Sandbox_c12/Label/1'>Tacrines ring</scene> is stacked between the aromatic rings of tryptophan 84 and phenylalanine 330 (<scene name='Sandbox_c12/Residuos_84_y_330/1'>W84 and F330</scene>)<ref>pmid 123</ref>
+
<scene name='Sandbox_c12/Label/1'>Tacrines ring</scene> is stacked between the aromatic rings of tryptophan 84 and phenylalanine 330 (<scene name='Sandbox_c12/Residuos_84_y_330/1'>W84 and F330</scene>)<ref>pmid 8415649</ref>
<references/>pmid 8415649.
<references/>pmid 8415649.

Revision as of 13:29, 23 November 2010

TcAChE

Drag the structure with the mouse to rotate

1ACJ shows the crystal structure of Torpedo californica acetylcholinesterase (TcAChE) complexed with tacrine.

Tacrine is a parasympathomimetic and a centrally acting cholinesterase inhibitor.

It was the first centrally-acting cholinesterase inhibitor approved for the treatment of Alzheimer's disease.

is stacked between the aromatic rings of tryptophan 84 and phenylalanine 330 ()[1]

  1. ↑ Harel M, Schalk I, Ehret-Sabatier L, Bouet F, Goeldner M, Hirth C, Axelsen PH, Silman I, Sussman JL. Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase. Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):9031-5. PMID:8415649
pmid 8415649.
Retrieved from "http://52.214.119.220/wiki/index.php/Sandbox_c12"
Personal tools